Inger Anne Næss

2.4k total citations · 1 hit paper
26 papers, 1.7k citations indexed

About

Inger Anne Næss is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Inger Anne Næss has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Internal Medicine, 13 papers in Hematology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Inger Anne Næss's work include Venous Thromboembolism Diagnosis and Management (16 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Acute Myocardial Infarction Research (4 papers). Inger Anne Næss is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (16 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Acute Myocardial Infarction Research (4 papers). Inger Anne Næss collaborates with scholars based in Norway, Netherlands and Denmark. Inger Anne Næss's co-authors include Suzanne C. Cannegieter, Jens Hammerstrøm, Sverre Christian Christiansen, Frits R. Rosendaal, Pål Romundstad, Sigrid K. Brækkan, Pieter H. Reitsma, F. R. Rosendaal, P. R. Romundstad and John‐Bjarne Hansen and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Inger Anne Næss

26 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and mortality of venous thrombosis: a population‐based study

2007 1.0k citations Inger Anne Næss, Sverre Christian Christiansen et al. Journal of Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inger Anne Næss Norway	15	1.2k	667	622	346	166	26	1.7k
Sverre Christian Christiansen Norway	15	1.5k 1.3×	982 1.5×	841 1.4×	504 1.5×	149 0.9×	33	2.1k
Pierpaolo Di Micco Italy	24	1.0k 0.8×	388 0.6×	842 1.4×	332 1.0×	212 1.3×	144	1.9k
Gilles Pernod France	27	1.6k 1.3×	652 1.0×	1.4k 2.3×	678 2.0×	182 1.1×	139	2.9k
Albert W. Tsai United States	11	1.3k 1.1×	705 1.1×	791 1.3×	492 1.4×	128 0.8×	15	2.1k
Fadi Kayali United States	20	1.2k 1.0×	391 0.6×	598 1.0×	383 1.1×	374 2.3×	27	1.7k
Gerd Lärfars Sweden	19	1.8k 1.5×	872 1.3×	1.2k 1.9×	720 2.1×	270 1.6×	46	2.5k
Patrick Brill-Edwards Canada	18	1.5k 1.2×	755 1.1×	1.0k 1.7×	591 1.7×	212 1.3×	29	2.0k
Jens Hammerstrøm Norway	22	1.2k 1.0×	737 1.1×	688 1.1×	429 1.2×	161 1.0×	68	2.5k
Patricia Vegh Canada	16	632 0.5×	1.2k 1.8×	404 0.6×	316 0.9×	100 0.6×	20	1.8k
Mauro Silingardi Italy	20	1.3k 1.1×	399 0.6×	1.1k 1.8×	376 1.1×	161 1.0×	50	2.1k

Countries citing papers authored by Inger Anne Næss

Since Specialization

Citations

This map shows the geographic impact of Inger Anne Næss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Anne Næss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Anne Næss more than expected).

Fields of papers citing papers by Inger Anne Næss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Anne Næss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Anne Næss. The network helps show where Inger Anne Næss may publish in the future.

Co-authorship network of co-authors of Inger Anne Næss

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Anne Næss. A scholar is included among the top collaborators of Inger Anne Næss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Anne Næss. Inger Anne Næss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crobach, Monique J. T., Sigrid K. Brækkan, Marianne Tang Severinsen, et al.. (2023). Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study. Blood Advances. 7(15). 4072–4079. 20 indexed citations

Severinsen, Marianne Tang, Jens Hammerstrøm, Søren Risom Kristensen, et al.. (2021). Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort. Scientific Reports. 11(1). 18752–18752. 5 indexed citations

Hveem, Kristian, Marianne Tang Severinsen, Maiken E. Gabrielsen, et al.. (2021). Prothrombotic genotypes and risk of venous thromboembolism in occult cancer. Thrombosis Research. 205. 17–23. 5 indexed citations

Næss, Inger Anne, et al.. (2021). Syfilis med synstap. Tidsskrift for Den norske legeforening. 141(1). 2 indexed citations

Severinsen, Marianne Tang, Suzanne C. Cannegieter, Kim Overvad, et al.. (2018). Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort. Journal of Thrombosis and Haemostasis. 16(7). 1327–1335. 17 indexed citations

Gade, Inger Lise, Sigrid K. Brækkan, Inger Anne Næss, et al.. (2018). Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort. SHILAP Revista de lepidopterología. 2(2). e131–e138. 4 indexed citations

Gade, Inger Lise, Sigrid K. Brækkan, Inger Anne Næss, et al.. (2017). The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort. Journal of Thrombosis and Haemostasis. 15(8). 1567–1575. 33 indexed citations

Gade, Inger Lise, Sigrid K. Brækkan, Inger Anne Næss, et al.. (2017). Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort. Thrombosis Research. 158. 157–160. 20 indexed citations

Brækkan, Sigrid K., Scott D. Grosse, Ekwutosi M. Okoroh, et al.. (2016). Venous thromboembolism and subsequent permanent work‐related disability. Journal of Thrombosis and Haemostasis. 14(10). 1978–1987. 35 indexed citations

10.

Severinsen, Marianne Tang, Jens Hammerstrøm, Sigrid K. Brækkan, et al.. (2015). Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort. Clinical Epidemiology. 7. 401–401. 22 indexed citations

11.

Grosse, Scott D., Ekwutosi M. Okoroh, Sigrid K. Brækkan, et al.. (2013). Venous thromboembolism and subsequent receipt of disability pension - a population-based prospective cohort study. Journal of Thrombosis and Haemostasis. 11. 442–443. 2 indexed citations

12.

Mahmoodi, Bakhtawar K., et al.. (2013). Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism Pooled Analysis of Five Prospective General Population Cohorts. Journal of Vascular Surgery. 57(2). 600–600. 6 indexed citations

13.

Debeij, J., Olaf M. Dekkers, Bjørn Olav Åsvold, et al.. (2012). Increased levels of free thyroxine and risk of venous thrombosis in a large population‐based prospective study. Journal of Thrombosis and Haemostasis. 10(8). 1539–1546. 25 indexed citations

14.

Christiansen, Sverre Christian, Willem M. Lijfering, Inger Anne Næss, et al.. (2012). The relationship between body mass index, activated protein C resistance and risk of venous thrombosis. Journal of Thrombosis and Haemostasis. 10(9). 1761–1767. 27 indexed citations

15.

Tangen, Jon‐Magnus, Yngvar Fløisand, Einar Haukås, et al.. (2010). Overlevelse hos voksne med akutt lymfoblastisk leukemi. Tidsskrift for Den norske legeforening. 130(17). 1710–1713. 2 indexed citations

16.

Quist‐Paulsen, Petter, Inger Anne Næss, Suzanne C. Cannegieter, et al.. (2009). Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica. 95(1). 119–125. 81 indexed citations

17.

Tangen, Jon‐Magnus, et al.. (2008). Overlevelse hos voksne med akutt myelogen leukemi. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

18.

Christiansen, Sverre Christian, Inger Anne Næss, Suzanne C. Cannegieter, et al.. (2006). Inflammatory Cytokines as Risk Factors for a First Venous Thrombosis: A Prospective Population-Based Study. PLoS Medicine. 3(8). e334–e334. 71 indexed citations

19.

Næss, Inger Anne, et al.. (2005). A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). Journal of Thrombosis and Haemostasis. 4(1). 44–49. 50 indexed citations

20.

Amundsen, Tore, Inger Anne Næss, Jens Hammerstrøm, Robert Brudevold, & Kristian S. Bjerve. (2002). [Lead poisoning--a case report].. PubMed. 122(15). 1471–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact